BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9108451)

  • 21. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.
    Montagnoli A; Fiore F; Eytan E; Carrano AC; Draetta GF; Hershko A; Pagano M
    Genes Dev; 1999 May; 13(9):1181-9. PubMed ID: 10323868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tumor necrosis factor-alpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells.
    Jeoung DI; Tang B; Sonenberg M
    J Biol Chem; 1995 Aug; 270(31):18367-73. PubMed ID: 7629160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells.
    Mal A; Chattopadhyay D; Ghosh MK; Poon RY; Hunter T; Harter ML
    J Cell Biol; 2000 Apr; 149(2):281-92. PubMed ID: 10769022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells.
    Seynaeve CM; Stetler-Stevenson M; Sebers S; Kaur G; Sausville EA; Worland PJ
    Cancer Res; 1993 May; 53(9):2081-6. PubMed ID: 7683251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer.
    Kawana H; Tamaru J; Tanaka T; Hirai A; Saito Y; Kitagawa M; Mikata A; Harigaya K; Kuriyama T
    Am J Pathol; 1998 Aug; 153(2):505-13. PubMed ID: 9708810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
    Akinaga S; Gomi K; Morimoto M; Tamaoki T; Okabe M
    Cancer Res; 1991 Sep; 51(18):4888-92. PubMed ID: 1893379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
    Steiner P; Philipp A; Lukas J; Godden-Kent D; Pagano M; Mittnacht S; Bartek J; Eilers M
    EMBO J; 1995 Oct; 14(19):4814-26. PubMed ID: 7588611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
    Dulić V; Kaufmann WK; Wilson SJ; Tlsty TD; Lees E; Harper JW; Elledge SJ; Reed SI
    Cell; 1994 Mar; 76(6):1013-23. PubMed ID: 8137420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.
    Furlanetto RW; Harwell SE; Frick KK
    Mol Endocrinol; 1994 Apr; 8(4):510-7. PubMed ID: 8052269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cyclin-dependent kinases by p21.
    Harper JW; Elledge SJ; Keyomarsi K; Dynlacht B; Tsai LH; Zhang P; Dobrowolski S; Bai C; Connell-Crowley L; Swindell E
    Mol Biol Cell; 1995 Apr; 6(4):387-400. PubMed ID: 7626805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.
    Firpo EJ; Koff A; Solomon MJ; Roberts JM
    Mol Cell Biol; 1994 Jul; 14(7):4889-901. PubMed ID: 7516474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
    Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
    Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early events in DNA replication require cyclin E and are blocked by p21CIP1.
    Jackson PK; Chevalier S; Philippe M; Kirschner MW
    J Cell Biol; 1995 Aug; 130(4):755-69. PubMed ID: 7642695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Lee MH; Reynisdóttir I; Massagué J
    Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect.
    Li CY; Suardet L; Little JB
    J Biol Chem; 1995 Mar; 270(10):4971-4. PubMed ID: 7890601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDK4/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1/S transition.
    Kim S; Leong A; Kim M; Yang HW
    Sci Rep; 2022 Oct; 12(1):16810. PubMed ID: 36207346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin.
    Poon RY; Hunter T
    Science; 1995 Oct; 270(5233):90-3. PubMed ID: 7569954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of the regulation of DNA synthesis by cdk2, Cip1, and licensing factor.
    Yan H; Newport J
    J Cell Biol; 1995 Apr; 129(1):1-15. PubMed ID: 7698977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
    Halevy O; Novitch BG; Spicer DB; Skapek SX; Rhee J; Hannon GJ; Beach D; Lassar AB
    Science; 1995 Feb; 267(5200):1018-21. PubMed ID: 7863327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.